Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 4, 2002, Pages 888-892

  Kaminski, Joseph M ^a   Hanlon, Alexandra L ^a   Horwitz, Eric M ^a   Pinover, Wayne H ^a   Mitra, Raj K ^a   Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Biochemical control; Prostate cancer; Prostate volume; PSA nadir

Indexed keywords

ANTIGENS; BIOCHEMISTRY; CORRELATION METHODS; PATIENT MONITORING; RADIOLOGY; RADIOTHERAPY; REGRESSION ANALYSIS;

PERINEURAL INVASION (PNI);

ONCOLOGY;

NADIR ANTIGEN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; ORGAN SIZE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE; PROSTATE ADENOCARCINOMA; RADIATION DOSE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALPATION; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0037086111     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02764-X     Document Type: Article

References (21)

1. An analysis of urinary prostate-specific antigen before and after radical prostatectomy: Evidence for secretion of prostate-specific antigen by the periurethral glands
2. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
3. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
4. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels
5. Human benign prostatic hyperplasia: A stromal disease? New perspectives by quantitative morphology
6. Dose selection for prostate cancer patients based on dose comparison and dose response studies
7. Defining the optimal radiation dose with 3D conformal radiation therapy for patients with non-metastatic prostate cancer using recursive partitioning techniques
8. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer
9. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era
10. 3-D conformal radiotherapy for prostate cancer: The University of Michigan experience
11. Stage T1-2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy
12. PSA following anatomical radical retropubic prostatectomy: An interim report
13. Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications
14. Simultaneous irradiation for prostate cancer: Intermediate results with modern techniques
15. Biochemical outcome following external beam radiation therapy for T1-T2 prostate carcinoma: The importance of achieving an undetectable nadir PSA
16. Prostate-specific antigen and RT for clinically localized prostate cancer
17. 3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer
18. Consensus statement: Guidelines for PSA following radiation therapy
19. Prostate
20. Nonparametric estimation from incomplete observations
21. Regression models and life tables